Moderna Inc. today announced an agreement with the U.S. government for the purchase of an additional 200 million doses of Moderna’s COVID-19 vaccine, along with an option to purchase other COVID-19 vaccine candidates in the biotech company’s development pipeline.

The purchase will bring the total number of federally owned doses to 500 million, with delivery stretching into 2022. Moderna said the additional doses could be used for primary vaccination, including children, for which Moderna has yet to receive Food and Drug Administration approval, or as a booster for those with waning antibody protection.

Related News Articles

Headline
All clinicians should get vaccinated against COVID-19, encourage their staff and patients to get vaccinated, and recommend immunocompromised patients continue…
Headline
The AHA, America’s Essential Hospitals, Association of American Medical Colleges, Catholic Health Association of the United States, and Children’s Hospital…
Headline
The Health Resources and Services Administration today awarded 127 organizations a total of $121 million in American Rescue Plan Act funds to work with…
Headline
The Federal Emergency Management Agency Friday released an advisory on reimbursable communications and outreach expenses for nonprofit medical facilities and…
Headline
Pfizer Inc. today announced that the federal government has agreed to purchase an additional 200 million doses of its COVID-19 vaccine. The deal raises the…
Headline
The Health Resources and Services Administration yesterday awarded rural health clinics about $49,500 each for outreach to increase COVID-19 vaccinations in…